RA Capital Management - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.

Quarter-by-quarter ownership
RA Capital Management ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2021$7,500,000
-29.5%
750,0000.0%0.10%
-39.2%
Q2 2021$10,635,000
-13.6%
750,0000.0%0.17%
-8.1%
Q1 2021$12,308,000
-20.7%
750,0000.0%0.19%
-14.3%
Q4 2020$15,525,000
-25.2%
750,000
-72.5%
0.22%
-42.9%
Q3 2020$20,755,000
-8.6%
2,727,2720.0%0.38%
-14.2%
Q2 2020$22,718,0002,727,2720.44%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders